Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2008, p. 1265-1273, Vol. 28, No. 4
0270-7306/08/$08.00+0 doi:10.1128/MCB.01108-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Heather A. Steinman,
Kathleen Hoover, and
Stephen N. Jones*
Departments of Cell Biology and Cancer Biology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655
Received 21 June 2007/ Returned for modification 31 July 2007/ Accepted 11 November 2007
Mdm2 and MdmX are structurally related p53-binding proteins that function as critical negative regulators of p53 activity in embryonic and adult tissue. The overexpression of Mdm2 or MdmX inhibits p53 tumor suppressor functions in vitro, and the amplification of Mdm2 or MdmX is observed in human cancers retaining wild-type p53. We now demonstrate a surprising role for MdmX in suppressing tumorigenesis that is distinct from its oncogenic ability to inhibit p53. The deletion of MdmX induces multipolar mitotic spindle formation and the loss of chromosomes from hyperploid p53-null cells. This reduction in chromosome number, not observed in p53-null cells with Mdm2 deleted, correlates with increased cell proliferation and the spontaneous transformation of MdmX/p53-null mouse embryonic fibroblasts in vitro and with an increased rate of spontaneous tumorigenesis in MdmX/p53-null mice in vivo. These results indicate that MdmX has a p53-independent role in suppressing oncogenic cell transformation, proliferation, and tumorigenesis by promoting centrosome clustering and bipolar mitosis.
Published ahead of print on 26 November 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
These authors contributed equally to this work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»